The 48 h change in lymphocyte CD4+ CTLA4+ co-expression showed significant differences among the three groups, particularly between the control and severe SLE groups, which suggested that the impaired function of CTLA-4/PD-1 expression after activation in severe SLE patients may be a contributing factor. The gene discussed is CTLA4; the disease is systemic lupus erythematosus.